MASCC 2020 recommendations for the management of immune-related adverse events of patients undergoing treatment with immune checkpoint inhibitors

被引:0
|
作者
Bernardo L. Rapoport
Ronald Anderson
Tim Cooksley
Douglas B. Johnson
机构
[1] University of Pretoria,Department of Immunology, Faculty of Health Sciences
[2] The Medical Oncology Centre of Rosebank,Department of Medicine
[3] Manchester University Foundation Trust,undefined
[4] The Christie,undefined
[5] University of Manchester,undefined
[6] Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center,undefined
来源
Supportive Care in Cancer | 2020年 / 28卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:6107 / 6110
页数:3
相关论文
共 50 条
  • [21] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [22] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sabina Sandigursky
    Adam Mor
    Current Rheumatology Reports, 2018, 20
  • [23] Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer
    Samanci, Nilay Sengul
    Cikman, Duygu Ilke
    Oruc, Kerem
    Bedir, Sahin
    Celik, Emir
    Degerli, Ezgi
    Derin, Sumeyra
    Demirelli, Fuat Hulusi
    Ozguroglu, Mustafa
    TUMORI JOURNAL, 2021, 107 (04): : 304 - 310
  • [24] Advanced materials for management of immune-related adverse events induced by immune checkpoint inhibitors
    Zheng, Lingnan
    Yang, Xi
    Wei, Yuanfeng
    You, Jia
    Li, Huawei
    Liao, Jinfeng
    Yi, Cheng
    MATERIALS & DESIGN, 2022, 219
  • [25] Immune-related Adverse Events: Overview and Management Strategies for the Use of Immune Checkpoint Inhibitors
    Jeung, Hei-Cheul
    Oh, Se Eung
    Kim, Jee Hung
    JOURNAL OF RHEUMATIC DISEASES, 2019, 26 (04): : 221 - 234
  • [26] Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management
    Ruggiero, Rosanna
    Di Napoli, Raffaella
    Balzano, Nunzia
    Ruggiero, Donatella
    Riccardi, Consiglia
    Anatriello, Antonietta
    Cantone, Andrea
    Sportiello, Liberata
    Rossi, Francesco
    Capuano, Annalisa
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (05) : 423 - 434
  • [27] Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review
    Stelmachowska-Banas, Maria
    Czajka-Oraniec, Izabella
    ENDOCRINE CONNECTIONS, 2020, 9 (10): : R207 - R228
  • [28] Management of challenging immune-related gastrointestinal adverse events associated with immune checkpoint inhibitors
    Hamamoto, Yasuo
    Shin, Natalya
    Hoshino, Tomohiro
    Kanai, Takanori
    FUTURE ONCOLOGY, 2018, 14 (30) : 3187 - 3198
  • [29] Beyond corticosteroids for the management of patients with cutaneous immune-related adverse events secondary to immune checkpoint inhibitors
    Yip, V.
    Olsson-Brown, A.
    Carr, D.
    Pirmohamed, M.
    Hindle, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 136 - 136
  • [30] Cutaneous immune-related adverse events to checkpoint inhibitors
    Malviya, Neeta
    Tattersall, Ian W.
    Leventhal, Jonathan
    Allon, Allireza
    CLINICS IN DERMATOLOGY, 2020, 38 (06) : 660 - 678